Výsledky vyhledávání

The spontaneous dissolution of 2D polytriazine imide (PTI) carbon nitrides in certain solvents diverges dramatically from the inherent insolubility of other 2D materials such as graphene. Here, the mechanism of dissolution and underlying factors whic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::5d2223269e54b2e4a47eb521dba88d85
https://eprints.whiterose.ac.uk/171280/1/d0ta11070a.pdf

Zobrazit plný text záznamu

Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

Autor: Teerlink, J.R. Diaz, R. Michael Felker, G. McMurray, J.J.V. Metra, M. Solomon, S.D. Adams, K.F. Anand, I. Arias-Mendoza, A. Biering-Sorensen, T. Bohm, M. Bonderman, D. Cleland, J.G.F. Corbalan, R. Crespo-Leiro, M.G. Dahlstrom, U. Echeverria, L.E. Fang, J.C. Filippatos, G. Fonseca, C. Goncalvesova, E. Goudev, A.R. Howlett, J.G. Lanfear, D.E. Li, J. Lund, M. Macdonald, P. Mareev, V. Momomura, S. O'Meara, E. Parkhomenko, A. Ponikowski, P. Ramires, F.J.A. Serpytis, P. Sliwa, K. Spinar, J. Suter, T.M. Tomcsanyi, J. Vandekerckhove, H. Vinereanu, D. Voors, A.A. Yilmaz, M.B. Zannad, F. Sharpsten, L. Legg, J.C. Varin, C. Honarpour, N. Abbasi, S.A. Malik, F.I. Kurtz, C.E.

BACKGROUND The selective cardiac myosin activator omecamtiv mecarbil has been shown to improve cardiac function in patients with heart failure with a reduced ejection fraction. Its effect on cardiovascular outcomes is unknown. METHODS We randomly ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::7d12fa9b34e469a722d2331d6152ddbe
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3102906

Zobrazit plný text záznamu

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology

Autor: Pudil, R. Mueller, C. Čelutkienė, J. Henriksen, P.A. Lenihan, D. Dent, S. Barac, A. Stanway, S. Moslehi, J. Suter, T.M. Ky, B. Štěrba, M. Cardinale, D. Cohen-Solal, A. Tocchetti, C.G. Farmakis, D. Bergler-Klein, J. Anker, M.S. Von Haehling, S. Belenkov, Y. Iakobishvili, Z. Maack, C. Ciardiello, F. Ruschitzka, F. Coats, A.J.S. Seferovic, P. Lainscak, M. Piepoli, M.F. Chioncel, O. Bax, J. Hulot, J.-S. Skouri, H. Hägler-Laube, E.S. Asteggiano, R. Fernandez, T.L. de Boer, R.A. Lyon, A.R.

Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases in cardiac biomarkers including cardiac troponin and natriuretic pept

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0e5fe57efb5d31c3f5fbc17e24ad4764
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103665

Zobrazit plný text záznamu

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

Autor: Lyon, A.R. Dent, S. Stanway, S. Earl, H. Brezden-Masley, C. Cohen-Solal, A. Tocchetti, C.G. Moslehi, J.J. Groarke, J.D. Bergler-Klein, J. Khoo, V. Tan, L.L. Anker, M.S. von Haehling, S. Maack, C. Pudil, R. Barac, A. Thavendiranathan, P. Ky, B. Neilan, T.G. Belenkov, Y. Rosen, S.D. Iakobishvili, Z. Sverdlov, A.L. Hajjar, L.A. Macedo, A.V.S. Manisty, C. Ciardiello, F. Farmakis, D. de Boer, R.A. Skouri, H. Suter, T.M. Cardinale, D. Witteles, R.M. Fradley, M.G. Herrmann, J. Cornell, R.F. Wechelaker, A. Mauro, M.J. Milojkovic, D. de Lavallade, H. Ruschitzka, F. Coats, A.J.S. Seferovic, P.M. Chioncel, O. Thum, T. Bauersachs, J. Andres, M.S. Wright, D.J. López-Fernández, T. Plummer, C. Lenihan, D.

This position statement from the Heart Failure Association of the European Society of Cardiology Cardio-Oncology Study Group in collaboration with the International Cardio-Oncology Society presents practical, easy-to-use and evidence-based risk strat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::d8494a06a08261135a88e9146f8f483e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103699

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání